constant support in therapy

A must-have app for every MS patient

Complements drug therapy and drug programs

Doctor.One is an app that supports the pharmacological treatment of MS patients to increase their engagement and adherence to therapeutic recommendations.

Complements drug therapy and drug programs

Doctor.One is an app that supports the pharmacological treatment of MS patients to increase their engagement and adherence to therapeutic recommendations.

Provides physicians with a tool to coordinate therapy

From the beginning of therapy, the patient is in constant contact with his attending physician through a secure medical chat between in-patient visits.

THE MAIN CHALLENGES

Why isn't pharmacotherapy everything?

Up to 25% of MS patients discontinue therapy prematurely ³

Treatment of MS requires the involvement of the patient and the therapeutic team. Side effects of therapy, lack of knowledge of its effectiveness and insufficient support from the doctor and the team can lead to low adherence, less effectiveness of treatment and even discontinuation of therapy.^{4 5 6 7 8 9}

MS patient sees his attending physician once every 3 months ¹⁰

Traditional medical care does not provide the patient with the continuity of the support of the attending physician, who coordinates therapy, educates about living with the disease and increases the patient's awareness of the effectiveness of the therapy.

OUR ANSWER

We effectively engage the MS patient in the initiation and continuation of therapy

The implementation of the Doctor.One application in the coordination of care for patients with multiple sclerosis is an answer to the main challenges and scientifically proposed solutions to increase adherence.

Increased Patient Engagement

Regular and uninterrupted communication with the doctor makes patients more committed to their therapy.

Better adherence in therapy

Support and education of the patient by the attending physician helps to better understand and adhere to medical recommendations.

Secure medical communication

The patient and the doctor have a safe and legal space to exchange information about the patient's health status.

value for the ecosystem

Each side is important to us

Medical staff

better control of the treatment process, safe and convenient communication with the patient, higher job satisfaction

Manufacturers of medicines

increased patient engagement and support, better adherence, fewer interrupted therapies

Patients

constant support of the attending physician, effective education about the disease and therapy, lower costs for commuting to the hospital, saving time

hospitals

fewer hospitalizations, shorter hospitalizations, better patient flow management, increased cost effectiveness

Doctors

better control of the treatment process, safe and convenient communication with the patient, higher job satisfaction

Patients

constant support of the attending physician, effective education about the disease and therapy, lower costs for commuting to the hospital, saving time

Manufacturers of medicines

constant support of the attending physician, increased involvement and support of patients, better adherence, fewer interrupted therapies

hospitals

fewer hospitalizations, shorter hospitalizations, better patient flow management, increased cost effectiveness

proofs

We measure the effectiveness of our implementation*

involvement in therapy

8x more

micro-interactions doctor-patient than in the case of appointments

Effectiveness of contact

88%

patients have increased their knowledge of the disease and treatment

access to care

20x faster

access to the doctor conducting the therapeutic process

quality of care

81%

Doctors see an improvement in the quality of care for their patients

positive experience

9/10

Patients very satisfied with the program

*Data from a six-month pilot program in collaboration with Novartis

reviews

Experiences of doctors and patients

“With the Doctor.One app, I can better control the treatment and respond faster to the needs of patients. It is a perfect complement to in-patient visits, which shortens the distance between us and improves the effectiveness of the therapy.”

Arkadiusz Stepos

Ph.D. med. neurologist

“I use Doctor.One because it offers real contact with the doctor, not some self-care games. At the beginning of my illness, such an application was a godsend for me. The doctor always wrote back quickly and courteously.”

MS Program Patient

at doctor.one since October 2023

“Thanks to the educational program implemented jointly with Doctor.One, patients with MS who are under pharmacological care have received key knowledge and support from the doctor. This helped them fully engage in therapy. We chose to partner with Doctor.One because of their deep understanding of needs and their unique ability to create synergies between business goals, physicians and patients.”

Anna Dziecielak

Head of Digital & Innovation
In Novartis

our vision

We humanize medical care,
Connecting doctors and their patients

Phase 1

Pilotage

The pilot project involved 10 neurologists, 173 patients and 5 hospitals from, Wrocław, Katowice, Lublin, Łódź and Szczecin.

phase 2

Continuation of implementation in 60 centers

As part of our collaboration with Novartis, we are planning another initiative to provide patients with educational support through the app Doctor.One.

phase 3

Systemic adjustment

Develop metrics to implement the Value Based Healthcare model to implement the solution systemically.

Phase 1

Pilotage

The pilot project, implemented in cooperation with Novartis, involved 10 neurologists, 173 patients and 5 hospitals in Wrocław, Katowice, Lublin, Łódź and Szczecin. The main objective of the pilot was to provide patients with education and access to the attending physician through the app Doctor.One.

phase 2

Continuation of implementation in 60 centers

As part of our collaboration with Novartis, we are planning another initiative to provide patients with educational support through the app Doctor.One.

phase 3

Systemic adjustment

Develop metrics to implement the Value Based Healthcare model to implement the solution systemically.

Footnotes

1. N = 10 doctors
2. N=173 patients
3. Patti F. (2010). Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence. Patient preference and adherence, 4, 1—9.
4. Mohr DC, Goodkin DE, Likosky W, Gatto N, Baumann KA, Rudick RA. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol. 1997 May; 54 (5) :531-3.
5. Costello K, Kennedy P, Scanzillo J. Recognizing nonadherence in patients with multiple sclerosis and maintaining treatment adherence in the long term. Medscape J Med. 2008; 10 (9) :225.
6. Kołtuniuk, A.; Chojdak-Łukasiewicz, J. Adherence to Therapy in Patients with Multiple Sclerosis — Review. Int. J. Approximately. Public Health Resolution 2022, 19, 2203.
7. Patti F. (2010). Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence. Patient preference and adherence, 4, 1—9.
8. Erbay Ö, Usta Yeşilbalkan Ö, Yüceyar N. Factors Affecting the Adherence to Disease-Modifying Therapy in Patients With Multiple Sclerosis. J Neurosci Nurs. 2018 Oct; 50 (5) :291-297.
9. Washington F, Langdon D. Factors affecting adherence to disease-modifying therapies in multiple sclerosis: a systematic review. J Neurol. 2022 Apr; 269 (4) :1861-1872.
10. Report “National Health Fund: Multiple Sclerosis.

Constant contact with the doctor revolutionizes the treatment of MS

9

/

10

97

%

A must-have app for every MS patient

Complements drug therapy and drug programs

Complements drug therapy and drug programs

Provides physicians with a tool to coordinate therapy

Why isn't pharmacotherapy everything?

Up to 25% of MS patients discontinue therapy prematurely 3

MS patient sees his attending physician once every 3 months 10

We effectively engage the MS patient in the initiation and continuation of therapy

The implementation of the Doctor.One application in the coordination of care for patients with multiple sclerosis is an answer to the main challenges and scientifically proposed solutions to increase adherence.

Each side is important to us

Medical staff

Manufacturers of medicines

Patients

hospitals

Doctors

Patients

Manufacturers of medicines

hospitals

We measure the effectiveness of our implementation*

8x more

88%

20x faster

81%

9/10

Experiences of doctors and patients

Arkadiusz Stepos

MS Program Patient

Anna Dziecielak

We humanize medical care,Connecting doctors and their patients

The problem of current medicine

Pilotage

Continuation of implementation in 60 centers

Systemic adjustment

User-centred approach

Pilotage

Continuation of implementation in 60 centers

Systemic adjustment

They appreciated our solution

Innovate with us

Empowering physicians with a medical messenger tailored to their needs

Contact us

Learn more

Help

Stay up to date

Up to 25% of MS patients discontinue therapy prematurely ³

MS patient sees his attending physician once every 3 months ¹⁰

We humanize medical care,
Connecting doctors and their patients